NewsRx

Search our medical news database

Diabetic Retinopathy

Scientists at University of Johannesburg report research in diabetic retinopathy

Published in Angiogenesis Weekly, October 23rd, 2009

"Multivariate statistical and graphical methods were used to compare high, medium, and low contrast visual acuities in right and left diabetic eyes with and without diabetic retinopathy (DR) and with and without diabetic macular edema (DME). Two hundred and two diabetic subjects were randomly recruited from a diabetic hospital clinic in Johannesburg," scientists writing in the journal Optometry and Vision Science report.

"Contrast visual acuities were measured using the new ETDRS visual acuity chart, at 100% (high contrast), 10% (medium), and 2.5% (low). For all eyes, retinal photographs were evaluated by two independent ophthalmologists and individuals were...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Angiogenesis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook